Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 42 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
411 19.0 months Hormone-refractory prostate cancer 4 Chemotherapy
Dana Farber Cancer Institute United States 12/2003
Treatment Details: Patients: This Phase II study involved 40 patients with hormone refractory prostate cancer. Median age was 68 years. The median years since diagnosis was 6 years. Thirty-five patients had
 
412 19.0 months Recurrent epithelial ovarian cancer 4 Chemotherapy
Sungkyunkwan University School of Medicine Korea 8/2009
Treatment Details: Patients: This phase 2 study involved 53 women with recurrent ovarian cancer. Their median age was 51, ranging from 30 to 77 years of age. The majority, 75.5%, were between the ages of 41
 
413 19.0 months recurrent ovarian cancer 4 Biologic therapy
Chemotherapy
University of Minnesota United States 1/2008
Treatment Details: Patients: This phase II trial involved 69 women with recurrent epithelial ovarian cancer. They ranged in age from 44 to 86 years of age. In the majority of these women, their cancer began
 
414 19.0 months colorectal (untreated metastatic) 3 Biologic therapy
Chemotherapy
University of North Carolina United States 7/2006
Treatment Details: Patients: This trial involved a total of 305 patients with previously untreated metastatic colorectal cancer. Patients were divided into two groups – Group A with 151 patients and Group B w
 
415 19.0 months GBM 5 Biologic therapy
Chemotherapy
Radiation
Memorial Sloan Kettering Cancer Center United States 10/2014
Treatment Details: Patients: This phase 2 study involved 40 glioblastoma patients. The median patient age was 55 years and 65% were male. Treatment: Patients received radiation therapy, chemotherapy with
 
416 19.0 months Metastatic colorectal cancer 5 Chemotherapy
Klinikum Sankt Marien Germany 1/2011
Treatment Details: Patients: This phase III study involved metastatic colorectal cancer patients who were divided into two separate treatment groups. Group A consisted of 238 patients with a median age of 63
 
417 19.0 months Castration-resistant prostate cancer 4 Chemotherapy
Institut Gustave Roussy France 4/2009
Treatment Details: Patients: This study involved 40 men with castration-resistant prostate cancer who had previously received docetaxel-based chemotherapy. The median age was 65 years. Treatment: Patient
 
418 19.0 months Metastatic breast cancer 4 Chemotherapy
Institut de Cancérologie de la Loire France 2/2012
Treatment Details: Patients: This study involved 20 previously untreated female patients with metastatic breast cancer with a median age of 62.5 years. Treatment: Patients were treated with the chemothera
 
419 19.0 months Advanced urothelial cancer 5 Chemotherapy
Athens University Medical School Greece 4/2013
Treatment Details: Patients: This phase 3 study involved advanced urothelial cancer patients who were divided into two separate treatment groups. Group A consisted of 63 patients with a median age of 66 year
 
420 19.0 months Metastatic breast cancer 4 Chemotherapy
University of Wisconsin School of Medicine and Public Health United States 3/2013
Treatment Details: Patients: This phase 2 study involved 10 female metastatic breast cancer patients with a median age of 56.5 years. Treatment: Patients were treated with the chemotherapy agents capecita
 
Page 42 of 187  | Previous Page  | Next Page